Yahoo Suche Web Suche

Suchergebnisse

1. Suchergebnisse:

1. www.nature.com › articles › s41408/024/01001-1Update on the management of relapsed/refractory chronic ... -...

   www.nature.com › articles › s41408/024/01001-1

   Update on the management of relapsed/refractory chronic lymphocytic leukemia. Rory Bennett1 and John F. Seymour 1,2 . The Author(s) 2024. Chronic lymphocytic leukemia (CLL) predominantly affects ...

2. pubmed.ncbi.nlm.nih.gov › 32358081Association of early disease progression and very poor ... -...

   pubmed.ncbi.nlm.nih.gov › 32358081

   John F Seymour 1 , Robert Marcus 2 , Andrew Davies 3 , Eve Gallop-Evans 4 , Andrew Grigg 5 , Andrew Haynes 6 , Michael Herold 7 , Thomas Illmer 8 , Herman Nilsson-Ehle 9 , Martin Sökler 10 , Ulrich Dünzinger 11 , Tina Nielsen 12 , Aino Launonen 12 , Wolfgang Hiddemann 13

3. pubmed.ncbi.nlm.nih.gov › 28089635Venetoclax plus rituximab in relapsed or refractory chronic ... -...

   pubmed.ncbi.nlm.nih.gov › 28089635

   John F Seymour 1 , Shuo Ma 2 , Danielle M Brander 3 , Michael Y Choi 4 , Jacqueline Barrientos 5 , Matthew S Davids 6 , Mary Ann Anderson 7 , Anne W Beaven 3 , Steven T Rosen 8 , Constantine S Tam 9 , Betty Prine 10 , Suresh K Agarwal 10 , Wijith Munasinghe 10 , Ming Zhu 10 , L Leanne Lash 10 , Monali Desai 10 , Elisa Cerri 10 , Maria Verdugo ...

4. pubmed.ncbi.nlm.nih.gov › 35983732Utility of measurable residual disease for predicting treatment...

   pubmed.ncbi.nlm.nih.gov › 35983732

   22. Aug. 2022 · William G Wierda 1 , Thomas J Kipps 2 , Othman Al-Sawaf 3 , Brenda Chyla 4 , Juliana M L Biondo 5 , Yong Mun 5 , Yanwen Jiang 5 , John F Seymour 6 Affiliations 1 University of Texas MD Anderson Cancer Center, Houston, TX, USA.

5. onlinelibrary.wiley.com › doi › epdf16th International Conference on Malignant Lymphoma Virtual...

   onlinelibrary.wiley.com › doi › epdf

   John F. Seymour, Melbourne (Australia) 13:30 – 13:45 Live Q&A Sunday, June 20, 2021 Time Channel Session Article/ abstract nr. 15:00 – 16:30 Channel 1 Educational symposium on High risk follicular lymphoma Co‐chairs: Elias Campo, Barcelona (Spain) and Carla Casulo, Rochester, NY (USA)

6. ashpublications.org › blood › articleAuthor notes - American Society of Hematology

   ashpublications.org › blood › article

   • Im Cache

   13. Nov. 2019 · John F. Seymour, Thomas J. Kipps, Barbara F. Eichhorst, Peter Hillmen, James D'Rozario, Sarit Assouline, Carolyn Owen, Tadeusz Robak, Javier de la Serna, Ulrich Jaeger, Guillaume Cartron, Marco Montillo, Nicole Lamanna, Su Young Kim, Jenny Wu, Yanwen Jiang, Jue Wang, Marcus Lefebure, Michelle Boyer, Kathryn Humphrey, Arnon P Kater; Four-Year Analysis of Murano Study Confirms Sustained Benefit ...

7. www.onclive.com › view › venetoclax-and-rituximab-combinationVenetoclax and Rituximab Combination Maintains Survival Benefit...

   www.onclive.com › view › venetoclax-and-rituximab-combination

   • Im Cache

   9. Okt. 2023 · Seymour JF, Kater AP, Harrup, et al. Final 7-year follow up and retreatment substudy analysis of MURANO: venetoclax-rituximab-treated patients with relapsed/refractory chronic lymphocytic leukemia ...